ClinicalTrials.gov record
A Study Comparing the Efficacy and Safety of Valdecoxib Plus Parecoxib Versus Valdecoxib Plus Placebo for the Treatment of Pain After Coronary Artery Bypass Surgery
ClinicalTrials.gov ID: NCT00636064
Public ClinicalTrials.gov record NCT00636064. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind Multicenter Study of the Safety and Efficacy of Parecoxib Sodium/Valdecoxib and Placebo/Valdecoxib Compared to Placebo for Treatment of Post-Surgical Pain in Patients Who Have Coronary Bypass Graft Via Median Sternotomy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of parecoxib/valdecoxib therapy and placebo/valdecoxib therapy for the treatment of pain after coronary artery bypass surgery
Study identification
- NCT ID
- NCT00636064
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,671 participants
Conditions and interventions
Conditions
Interventions
- Parecoxib Sodium/Valdecoxib Drug
- Placebo/Valdecoxib Drug
- Placebo/Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2002
- Primary completion
- Not listed
- Completion
- Dec 31, 2003
- Last update posted
- Oct 9, 2008
2003 – 2004
United States locations
- U.S. sites
- 84
- U.S. states
- 27
- U.S. cities
- 64
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Fairhope | Alabama | 36532 | — |
| Pfizer Investigational Site | Mobile | Alabama | 36602 | — |
| Pfizer Investigational Site | Mobile | Alabama | 36604 | — |
| Pfizer Investigational Site | Mobile | Alabama | 36607 | — |
| Pfizer Investigational Site | Mobile | Alabama | 36608 | — |
| Pfizer Investigational Site | Tucson | Arizona | 85724 | — |
| Pfizer Investigational Site | Fayetteville | Arkansas | 72703 | — |
| Pfizer Investigational Site | Springdale | Arkansas | 72764 | — |
| Pfizer Investigational Site | Anaheim | California | 92801 | — |
| Pfizer Investigational Site | Anaheim | California | 92805 | — |
| Pfizer Investigational Site | Los Angeles | California | 90033 | — |
| Pfizer Investigational Site | Los Angeles | California | 90095-1778 | — |
| Pfizer Investigational Site | Orange | California | 92868 | — |
| Pfizer Investigational Site | Sacramento | California | 95819 | — |
| Pfizer Investigational Site | Sacramento | California | 95825 | — |
| Pfizer Investigational Site | San Francisco | California | 94115 | — |
| Pfizer Investigational Site | San Francisco | California | 94118-3110 | — |
| Pfizer Investigational Site | San Francisco | California | 94143-0648 | — |
| Pfizer Investigational Site | Santa Rosa | California | 95403 | — |
| Pfizer Investigational Site | Santa Rosa | California | 95404 | — |
| Pfizer Investigational Site | Stanford | California | 94305 | — |
| Pfizer Investigational Site | Fort Collins | Colorado | 80524 | — |
| Pfizer Investigational Site | Fort Collins | Colorado | 80528 | — |
| Pfizer Investigational Site | New Haven | Connecticut | 06504 | — |
| Pfizer Investigational Site | New Haven | Connecticut | 06520 | — |
| Pfizer Investigational Site | Washington D.C. | District of Columbia | 20010 | — |
| Pfizer Investigational Site | Brandon | Florida | 33511 | — |
| Pfizer Investigational Site | Clearwater | Florida | 33756 | — |
| Pfizer Investigational Site | Hudson | Florida | 34667 | — |
| Pfizer Investigational Site | Jacksonville | Florida | 32216 | — |
| Pfizer Investigational Site | Melbourne | Florida | 32901-3276 | — |
| Pfizer Investigational Site | Melbourne | Florida | 32901 | — |
| Pfizer Investigational Site | Pensacola | Florida | 32504 | — |
| Pfizer Investigational Site | Pensacola | Florida | 32514 | — |
| Pfizer Investigational Site | Sarasota | Florida | 34239 | — |
| Pfizer Investigational Site | St. Petersburg | Florida | 33709 | — |
| Pfizer Investigational Site | Tampa | Florida | 33613 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30322 | — |
| Pfizer Investigational Site | Augusta | Georgia | 30901 | — |
| Pfizer Investigational Site | Fort Wayne | Indiana | 46804 | — |
| Pfizer Investigational Site | Iowa City | Iowa | 52242 | — |
| Pfizer Investigational Site | Kansas City | Kansas | 66160 | — |
| Pfizer Investigational Site | Baltimore | Maryland | 21215 | — |
| Pfizer Investigational Site | Salisbury | Maryland | 21801 | — |
| Pfizer Investigational Site | Takoma Park | Maryland | 20912 | — |
| Pfizer Investigational Site | Towson | Maryland | 21204 | — |
| Pfizer Investigational Site | Boston | Massachusetts | 02215 | — |
| Pfizer Investigational Site | Cambridge | Massachusetts | 02138 | — |
| Pfizer Investigational Site | Detroit | Michigan | 48202 | — |
| Pfizer Investigational Site | Livonia | Michigan | 48150 | — |
| Pfizer Investigational Site | Muskegon | Michigan | 49444 | — |
| Pfizer Investigational Site | Royal Oak | Michigan | 48073 | — |
| Pfizer Investigational Site | New York | New York | 10029 | — |
| Pfizer Investigational Site | Rochester | New York | 14621 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45219 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45236 | — |
| Pfizer Investigational Site | Dayton | Ohio | 45408 | — |
| Pfizer Investigational Site | Dayton | Ohio | 45414 | — |
| Pfizer Investigational Site | Sandusky | Ohio | 44870 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73112 | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | 74104 | — |
| Pfizer Investigational Site | Portland | Oregon | 97210 | — |
| Pfizer Investigational Site | Altoona | Pennsylvania | 16601 | — |
| Pfizer Investigational Site | Pittsburgh | Pennsylvania | 15212 | — |
| Pfizer Investigational Site | Pittsburgh | Pennsylvania | 15224 | — |
| Pfizer Investigational Site | Charleston | South Carolina | 29401 | — |
| Pfizer Investigational Site | Charleston | South Carolina | 29406 | — |
| Pfizer Investigational Site | Charleston | South Carolina | 29424 | — |
| Pfizer Investigational Site | Charleston | South Carolina | 29425 | — |
| Pfizer Investigational Site | Memphis | Tennessee | 38120 | — |
| Pfizer Investigational Site | Amarillo | Texas | 79106 | — |
| Pfizer Investigational Site | Fort Worth | Texas | 76107-2699 | — |
| Pfizer Investigational Site | Fort Worth | Texas | 76107 | — |
| Pfizer Investigational Site | Houston | Texas | 77030 | — |
| Pfizer Investigational Site | Irving | Texas | 75061 | — |
| Pfizer Investigational Site | Burlington | Vermont | 05401 | — |
| Pfizer Investigational Site | Annandale | Virginia | 22003 | — |
| Pfizer Investigational Site | Falls Church | Virginia | 22042 | — |
| Pfizer Investigational Site | Fredericksburg | Virginia | 22401 | — |
| Pfizer Investigational Site | Norfolk | Virginia | 23507 | — |
| Pfizer Investigational Site | Tacoma | Washington | 98405 | — |
| Pfizer Investigational Site | Elkhorn | Wisconsin | 53121 | — |
| Pfizer Investigational Site | Madison | Wisconsin | 53792 | — |
| Pfizer Investigational Site | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 122 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00636064, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 9, 2008 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00636064 live on ClinicalTrials.gov.